HPLC, UHPLC
Trastuzumab High Resolution Separation with new HALO 1000Å C4 columns
Mar 22 2017
A new application note demonstrating the high resolution separation of the monoclonal antibody trastuzumab has been published by Advanced Materials Technology (AMT). The separation is acheived in approximately five minutes at 80°C, under gradient conditions with UV detection.
Trastuzumab (MW ~148 kDa) is used to treat breast cancer. Enhanced resolution of trastuzumab and its variants is acheived using a new HALO 1000Å C4 column. HALO 1000Å C4 columns contain the world’s first 2.7 micron superficially porous silica particles with 1000Å pores. The pore size and structure of these particles enable molecules to achieve complete penetration of the porous structure, allowing enhanced interaction with more of the bonded surface for better retention and selectivity. This results in improved separations of these types of large molecules.
This application note and a technical brochure are available from Hichrom Limited and demonstrate the ability of HALO 1000Å C4 to provide valuable detailed information not possible to acheive when using particles with smaller pore sizes. For more information or a copy of the technical brochure please email.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Sep 04 2024 Chiba, Tokyo, Japan